Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent Ruby Khatun Khatun6 Oct 2017 11:12 AM ISTAHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
US pressing India to avoid capping medical device prices, allow withdrawals Ruby Khatun Khatun6 Oct 2017 10:33 AM ISTNew Delhi: The United States is pressing India not to extend price caps on medical devices and wants the government to allow firms to withdraw...
Fosun Pharma acquires 74 percent stake in Gland Pharma for 1.09 billion dollar Ruby Khatun Khatun5 Oct 2017 10:53 AM ISTNew Delhi: Chinese drug firm Fosun Pharma has acquired approximately 74 percent in Hyderabad-based Gland Pharma at a valuation of not more than USD...
Malaysian state keen to collaborate with India on biotech, ICT Ruby Khatun Khatun5 Oct 2017 9:20 AM ISTNew Delhi: Malaysian state of Selangor has expressed interest in collaborating with India in the fields of biotechnology, ICT, life sciences,...
NPPA allows Abbott to withdraw bioresorbable stent from India Ruby Khatun Khatun22 Sept 2017 5:00 PM ISTNew Delhi: Through a recent notice, Government of India , Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
Fosun Pharma to buy 74 percent stake in Gland Pharma for 1.1 billion dollar Ruby Khatun Khatun19 Sept 2017 10:47 AM ISTBEIJING/MUMBAI: Shanghai Fosun Pharmaceutical Group is trimming the size of the stake it will buy in India's Gland Pharma to 74 percent for $1.1...
Blockbuster cancer drug Keytruda launched in India Ruby Khatun Khatun14 Sept 2017 11:29 AM ISTNew Delhi: US-based drug major MSD said it has launched cancer drug Keytruda in India for treatment of advanced melanoma, a form of skin cancer.The...
Lupin to add GLP 1 analog to its diabetes portfolio in India Ruby Khatun Khatun13 Sept 2017 3:07 PM ISTMumbai: Lupin plans to introduce a new class of diabetes drugs in India through in-licensing agreements in order to enhance its diabetes drugs...
Sanofi launches Combiflam Icyhot pain relief topical in India Ruby Khatun Khatun12 Sept 2017 12:35 PM ISTMumbai: Sanofi India on Monday said it has expanded its consumer healthcare portfolio by launching Combiflam Icyhot, a topical analgesic in the...
Abbott pulls back its bioresorbable stent-ABSORB, also moves to withdraw XIENCE from India Ruby Khatun Khatun11 Sept 2017 3:17 PM ISTNew Delhi: Abbott has taken up the decision to stop the sales of sales of its bioresorbable coronary stent 'Absorb' globally due to low commercial...
Yakult Danone to launch new probiotic products Ruby Khatun Khatun10 Sept 2017 11:06 AM ISTNew Delhi: Yakult Danone, the manufacturer of milk-based fermented probiotic drinks, might consider the launch of new products in the Indian market...
OrbiMed lines up 551 million dollar healthcare PE fund for China, India Ruby Khatun Khatun9 Sept 2017 10:17 AM ISTNEW YORK: OrbiMed, a leading investment firm focused on the healthcare sector, announced the closing of its third Asia-focused private equity fund,...
